Patents Assigned to UNIVERSITY OF WASHINGTON, THE
-
Publication number: 20240189481Abstract: Described herein are compositions and methods relating to the improvement of cardiac function. Various embodiments relate to transplant compositions comprising cardiomyocytes which are engineered to be non-contractile, and to methods of using such cardiomyocytes or transplant compositions to improve cardiac function, e.g., by administering them to cardiac tissue.Type: ApplicationFiled: April 6, 2022Publication date: June 13, 2024Applicant: UNIVERSITY OF WASHINGTONInventors: Charles E. MURRY, Michael REGNIER, Hans REINECKE, Xiulan YANG, Dasom YOO
-
Patent number: 12006545Abstract: Next Generation DNA sequencing promises to revolutionize clinical medicine and basic research. However, while this technology has the capacity to generate hundreds of billions of nucleotides of DNA sequence in a single experiment, the error rate of approximately 1% results in hundreds of millions of sequencing mistakes. These scattered errors can be tolerated in some applications but become extremely problematic when “deep sequencing” genetically heterogeneous mixtures, such as tumors or mixed microbial populations. To overcome limitations in sequencing accuracy, a method Duplex Consensus Sequencing (DCS) is provided. This approach greatly reduces errors by independently tagging and sequencing each of the two strands of a DNA duplex. As the two strands are complementary, true mutations are found at the same position in both strands. In contrast, PCR or sequencing errors will result in errors in only one strand.Type: GrantFiled: August 2, 2021Date of Patent: June 11, 2024Assignee: UNIVERSITY OF WASHINGTON THROUGH ITS CENTER FOR COMMERCIALIZATIONInventors: Jesse Salk, Lawrence A. Loeb, Michael Schmitt
-
Patent number: 12006532Abstract: The present technology relates generally to methods and compositions for targeted nucleic acid sequence enrichment, as well as uses of such enrichment for error-corrected nucleic acid sequencing applications. In some embodiments, highly accurate, error corrected and massively parallel sequencing of nucleic acid material is possible using a combination of uniquely labeled strands in a double-stranded nucleic acid complex in such a way that each strand can be informatically related to its complementary strand, but also distinguished from it following sequencing of each strand or an amplified product derived therefrom. In various embodiments, this information can be used for the purpose of error correction of the determined sequence.Type: GrantFiled: September 16, 2022Date of Patent: June 11, 2024Assignee: UNIVERSITY OF WASHINGTONInventors: Scott R. Kennedy, Jesse J. Salk, Michael Hipp, Elizabeth Schmidt, Rosa Ana Risques, Daniela Nachmanson
-
Publication number: 20240182964Abstract: Methods and kits for uniquely labeling nucleic acid molecules within a plurality of microbial cells are described. In an embodiment, the method comprises fixing and permeabilizing the plurality of microbial cells; dissociating microbial cell aggregates within a suspension comprising the plurality of microbial cells; reverse transcribing mRNA within the plurality of microbial cells to provide cDNA; and combinatorially labelling the cDNA to provide labelled cDNA.Type: ApplicationFiled: January 8, 2024Publication date: June 6, 2024Applicant: University Of WashingtonInventors: Georg Seelig, Anna Kuchina, Leandra Brettner, William DePaolo
-
Publication number: 20240182924Abstract: Provided herein are methods for identifying high potency genomic insulator elements that can be used in a vector composition e.g., that are useful for preventing unwanted expression of neighboring genes, such as proto-oncogenes, when administered to a subject in need thereof. Also provided herein are methods for treating disease and methods for administering a nucleic acid to a subject using such vectors.Type: ApplicationFiled: September 7, 2023Publication date: June 6, 2024Applicant: University of WashingtonInventors: George Stamatoyannopoulos, John Stamatoyannopoulos
-
Publication number: 20240184359Abstract: Techniques for tracking eye movement in an augmented reality system identify a plurality of base images of an object or a portion thereof. A search image may be generated based at least in part upon at least some of the plurality of base images. A deep learning result may be generated at least by performing a deep learning process on a base image using a neural network in a deep learning mode. A captured image may be localized at least by performing an image registration process on the captured image and the search image using a Kalman filter model and the deep learning result.Type: ApplicationFiled: December 19, 2023Publication date: June 6, 2024Applicants: UNIVERSITY OF WASHINGTON, MAGIC LEAP, INC.Inventors: Eric J. SEIBEL, Steven L. BRUNTON, Chen GONG, Brian T. SCHOWENGERDT
-
Patent number: 11999951Abstract: Contiguity information is important to achieving high-quality de novo assembly of mammalian genomes and the haplotype-resolved resequencing of human genomes. The methods described herein pursue cost-effective, massively parallel capture of contiguity information at different scales.Type: GrantFiled: April 8, 2022Date of Patent: June 4, 2024Assignee: University of Washington through its Center for CommercializationInventors: Jay Ashok Shendure, Jerrod Joseph Schwartz, Andrew Colin Adey, Cho li Lee, Joseph Brian Hiatt, Jacob Otto Kitzman, Akash Kumar
-
Publication number: 20240173463Abstract: Portable hemodialysis systems include a dialysis fluid module configured to regenerate a dialysis fluid, and a blood handling module reversibly fluidically couplable to the dialysis fluid module. The portable hemodialysis system is configured to dialyze blood in the blood handling module using the dialysis fluid regenerated by the dialysis fluid module.Type: ApplicationFiled: March 22, 2022Publication date: May 30, 2024Applicant: University of WashingtonInventors: Barry Fulkerson, Jeremy Barribeau, Anna Galperin
-
Patent number: 11993815Abstract: Next Generation DNA sequencing promises to revolutionize clinical medicine and basic research. However, while this technology has the capacity to generate hundreds of billions of nucleotides of DNA sequence in a single experiment, the error rate of approximately 1% results in hundreds of millions of sequencing mistakes. These scattered errors can be tolerated in some applications but become extremely problematic when “deep sequencing” genetically heterogeneous mixtures, such as tumors or mixed microbial populations. To overcome limitations in sequencing accuracy, a method Duplex Consensus Sequencing (DCS) is provided. This approach greatly reduces errors by independently tagging and sequencing each of the two strands of a DNA duplex. As the two strands are complementary, true mutations are found at the same position in both strands. In contrast, PCR or sequencing errors will result in errors in only one strand.Type: GrantFiled: August 2, 2021Date of Patent: May 28, 2024Assignee: UNIVERSITY OF WASHINGTON THROUGH ITS CENTER FOR COMMERCIALIZATIONInventors: Jesse Salk, Lawrence A. Loeb, Michael Schmitt
-
Publication number: 20240165214Abstract: Methods that stabilize allosteric cell attachment proteins in either an active or inactive conformation enable toggling a protein between conformational states by restricting the repacking of side chains that occurs during the conformational transition. This restriction traps the protein in the desired high affinity or low affinity state. An allosteric cell attachment protein stabilized in an ‘active’ (high-affinity) or ‘inactive’ (low-affinity) conformation is stabilized by the substitution of a hydrophobic amino acid residue with a charged amino acid, in some embodiments, the attachment protein is bacterial. In some embodiments, the attachment protein is viral, in some embodiments, the protein is a bacterial adhesin.Type: ApplicationFiled: February 25, 2022Publication date: May 23, 2024Applicant: UNIVERSITY OF WASHINGTONInventors: Evgeni V. Sokurenko, Dagmara Kisiela, Pearl Magala, Wendy Evelyn Thomas, Rachel E. Klevit
-
Patent number: 11989216Abstract: In some embodiments, techniques are provided for conducting similarity-based searches using DNA. In some embodiments, sets of features that represent stored data sets are encoded in DNA sequences such that a hybridization yield between a molecule having a given stored DNA sequence and a molecule having a reverse complement of a DNA sequence that encodes a set of features that represent a query data set reflects an amount of similarity between the set of features that represent the query data set and the set of features encoded in the given stored DNA sequence. In some embodiments, machine learning techniques are used to determine the DNA sequence encoding. In some embodiments, machine learning techniques are used to predict hybridization yields between DNA molecules.Type: GrantFiled: April 9, 2020Date of Patent: May 21, 2024Assignees: University of Washington, Microsoft Technology Licensing, LLCInventors: Luis Ceze, Karin Strauss, Georg Seelig, Callie Bee, Yuan-Jyue Chen
-
Patent number: 11987838Abstract: Methods of uniquely labeling or barcoding molecules within a cell, a plurality of cells, and/or a tissue are provided. Kits for uniquely labeling or barcoding molecules within a cell, a plurality of cells, and/or a tissue are also provided. The molecules to be labeled may include, but are not limited to, RNAs, cDNAs, DNAs, proteins, peptides, and/or antigens.Type: GrantFiled: December 12, 2023Date of Patent: May 21, 2024Assignee: University of WashingtonInventors: Georg Seelig, Richard Muscat, Alexander B. Rosenberg
-
Publication number: 20240158854Abstract: Example spatial transcriptomics techniques use “continuous” polony arrays on a customized gel surface for spatial barcoding. By screening polyacrylamide (PAA) gel fabrication conditions, polonies formed on a crosslinked PAA gel were shown to exhibit a continuous, homogenous DNA distribution, which is highly suited for tissue barcoding applications. Compared with widely used polonies formed in flow cells that utilize linear PAA gels, continuous polonies showed efficient DNA amplification and restriction digestion to generate capture oligo arrays, which have a significantly better spatial RNA capturing performance. In addition, the crosslinked PAA gel showed sufficient constraints on lateral RNA diffusion and provides better mechanical strength and stability for tissue mapping assays than a semifluidic linear PAA gel used by previous methods.Type: ApplicationFiled: March 11, 2022Publication date: May 16, 2024Applicant: University of WashingtonInventors: Liangcai Gu, Xiaonan Fu, Shin Lin, Li Sun
-
Publication number: 20240158846Abstract: The present disclosure generally relates to the methods and compositions to efficiently analyze polymer characteristics using nanopore-based assays. Specifically disclosed is a method for generating reference signals for polymer analysis in a nanopore system, wherein the nanopore system has a multi-subunit output signal resolution. The method comprises translocating a reference sequence through a nanopore to generate a plurality of reference output signals, wherein each possible multi-subunit sequence that can determine an output signal appears only once in the reference sequence. The output signals are compiled into a reference map for nanopore analysis of an analyte polymer. Also provided are methods and compositions for calibrating the nanopore system for optimized polymer analysis.Type: ApplicationFiled: October 12, 2023Publication date: May 16, 2024Applicant: University of Washington through its Center for CommercializationInventors: Jens Gundlach, Ian M. Derrington, Andrew Laszlo, Elizabeth Manrao
-
Publication number: 20240157333Abstract: Thin layer chromatography (TEC) devices for the analysis of pico-scale samples, methods for using the devices, and methods for fabricating the devices.Type: ApplicationFiled: March 7, 2022Publication date: May 16, 2024Applicant: UNIVERSITY OF WASHINGTONInventors: Nancy Allbritton, Yuli Wang
-
Patent number: 11981891Abstract: Provided herein are methods for preparing a sequencing library that includes nucleic acids from a plurality of single cells. In one embodiment, the methods include linear amplification of the nucleic acids. In one embodiment, the sequencing library includes whole genome nucleic acids from the plurality of single cells. In one embodiment, the nucleic acids include three index sequences. Also provided herein are compositions, such as compositions that include the nucleic acids having three index sequences.Type: GrantFiled: May 17, 2019Date of Patent: May 14, 2024Assignees: Illumina, Inc., University of WashingtonInventors: Frank J. Steemers, Jay Shendure, Yi Yin
-
Patent number: 11982678Abstract: Provided herein, among other aspects, are methods and apparatuses for ranking aliquots from a suspension containing bioparticles. In certain embodiments, the bioparticles may be cells, organelles, proteins, DNAs, debris of biological origin, microbeads coated with biological compounds, or viral particles. As such, the methods and apparatuses provided herein may be used to quantify rare cells such as circulating cancer cells, fetal cells and other rare cells present in bodily fluids for disease diagnosis, prognosis, or treatment.Type: GrantFiled: October 26, 2018Date of Patent: May 14, 2024Assignee: UNIVERSITY OF WASHINGTON THROUGH ITS CENTER FOR COMMERCIALIZATIONInventors: Daniel T. Chiu, Perry G. Schiro, Jason S. Kuo
-
Publication number: 20240148289Abstract: A method of measuring blood oxygenation including acquiring one or more images of a portion of a body with an RGB camera, converting RGB colors in the one or more images into a multispectral data imaging cube, wherein the multispectral date imaging cube comprises a red channel, a blue channel, and a green channel, decoupling an oxygenated blood information and a deoxygenated blood information from the multispectral data imaging cube based on a first reflectance of the green channel and a second reflectance of the red channel, and determining a blood measurement based on the oxygenated blood information and the deoxygenated blood information.Type: ApplicationFiled: February 25, 2022Publication date: May 9, 2024Applicant: University of WashingtonInventors: Ruikang K. Wang, Qinghau He
-
Patent number: 11970740Abstract: Next Generation DNA sequencing promises to revolutionize clinical medicine and basic research. However, while this technology has the capacity to generate hundreds of billions of nucleotides of DNA sequence in a single experiment, the error rate of approximately 1% results in hundreds of millions of sequencing mistakes. These scattered errors can be tolerated in some applications but become extremely problematic when “deep sequencing” genetically heterogeneous mixtures, such as tumors or mixed microbial populations. To overcome limitations in sequencing accuracy, a method Duplex Consensus Sequencing (DCS) is provided. This approach greatly reduces errors by independently tagging and sequencing each of the two strands of a DNA duplex. As the two strands are complementary, true mutations are found at the same position in both strands. In contrast, PCR or sequencing errors will result in errors in only one strand.Type: GrantFiled: August 2, 2021Date of Patent: April 30, 2024Assignee: UNIVERSITY OF WASHINGTON THROUGH ITS CENTER FOR COMMERCIALIZATIONInventors: Jesse Salk, Lawrence A. Loeb, Michael Schmitt
-
Publication number: 20240131132Abstract: Antibodies that bind the tumor (T) antigen of the Merkel cell polyomavirus are disclosed. The antibodies can be use used in cell-based immunotherapies, antibody-based therapies, diagnostics, and detection assays, among other uses.Type: ApplicationFiled: October 22, 2023Publication date: April 25, 2024Applicants: Fred Hutchinson Cancer Center, University of WashingtonInventors: Justin J. Taylor, Denise Galloway, Paul Nghiem, David Koelle, Haroldo Rodriguez, Joseph Carter